FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller

The U.S. Food and Drug Administration has declined to approve an abuse-deterrent version of Mallinckrodt Plc's opioid painkiller Roxicodone, saying some parts of the company's application need further evaluation.